DE69221118T2 - Zielkomponenten-Assay - Google Patents

Zielkomponenten-Assay

Info

Publication number
DE69221118T2
DE69221118T2 DE69221118T DE69221118T DE69221118T2 DE 69221118 T2 DE69221118 T2 DE 69221118T2 DE 69221118 T DE69221118 T DE 69221118T DE 69221118 T DE69221118 T DE 69221118T DE 69221118 T2 DE69221118 T2 DE 69221118T2
Authority
DE
Germany
Prior art keywords
vesicles
sample
target
mixture
target component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69221118T
Other languages
German (de)
English (en)
Other versions
DE69221118D1 (de
Inventor
Judith Britz
Robert A Levine
Thomas J Mercolino
Rodolfo Rodriguez
Stephen C Wardlaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of DE69221118D1 publication Critical patent/DE69221118D1/de
Application granted granted Critical
Publication of DE69221118T2 publication Critical patent/DE69221118T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69221118T 1992-02-25 1992-12-01 Zielkomponenten-Assay Expired - Fee Related DE69221118T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (2)

Publication Number Publication Date
DE69221118D1 DE69221118D1 (de) 1997-09-04
DE69221118T2 true DE69221118T2 (de) 1998-02-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69221118T Expired - Fee Related DE69221118T2 (de) 1992-02-25 1992-12-01 Zielkomponenten-Assay

Country Status (17)

Country Link
US (1) US5593848A (enExample)
EP (1) EP0557595B1 (enExample)
JP (1) JP2925105B2 (enExample)
CN (1) CN1091521A (enExample)
AT (1) ATE155889T1 (enExample)
AU (1) AU662571B2 (enExample)
BR (1) BR9300639A (enExample)
CA (1) CA2090282A1 (enExample)
DE (1) DE69221118T2 (enExample)
DK (1) DK0557595T3 (enExample)
ES (1) ES2106121T3 (enExample)
FI (1) FI930821L (enExample)
GR (1) GR3024970T3 (enExample)
MX (1) MX9300965A (enExample)
NO (1) NO930649L (enExample)
RU (1) RU2116068C1 (enExample)
TW (1) TW246716B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
CA2253965C (en) * 1997-11-22 2003-01-21 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
IL139585A0 (en) * 1998-06-26 2002-02-10 Pfizer Prod Inc Improved process for preparing schiff base adducts of amines with 0-hydroxy aldehydes and compositions of matter based thereon
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
CA2504481A1 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1648299A4 (en) * 2003-07-09 2008-10-22 California Pacific Med Center REMOTE DETERMINATION OF THE DELIVERY OF SUBSTANCES IN CELLS
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
CA2720068C (en) 2008-04-02 2013-11-19 Abbott Point Of Care, Inc. Virtual separation of bound and free label in a ligand assay for performing immunoassays of biological fluids, including whole blood
WO2009126505A1 (en) * 2008-04-09 2009-10-15 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
EP3292221B1 (en) * 2015-05-06 2021-06-23 Seracare Life Sciences Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
JPS6345563A (ja) * 1986-04-11 1988-02-26 Hitachi Ltd 細胞分析方法
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
CA2033010A1 (en) * 1989-12-22 1991-06-23 Rajeev Ramanathan Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
RU2116068C1 (ru) 1998-07-27
FI930821A0 (fi) 1993-02-24
BR9300639A (pt) 1993-08-31
JP2925105B2 (ja) 1999-07-28
JPH0821833A (ja) 1996-01-23
ATE155889T1 (de) 1997-08-15
EP0557595A3 (enExample) 1993-11-10
US5593848A (en) 1997-01-14
NO930649D0 (no) 1993-02-24
EP0557595B1 (en) 1997-07-23
DK0557595T3 (da) 1997-12-29
FI930821A7 (fi) 1993-08-26
FI930821L (fi) 1993-08-26
CA2090282A1 (en) 1993-08-26
EP0557595A2 (en) 1993-09-01
MX9300965A (es) 1994-08-31
CN1091521A (zh) 1994-08-31
NO930649L (no) 1993-08-26
AU662571B2 (en) 1995-09-07
GR3024970T3 (en) 1998-01-30
AU2983692A (en) 1993-08-26
DE69221118D1 (de) 1997-09-04
TW246716B (enExample) 1995-05-01
ES2106121T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
DE69221118T2 (de) Zielkomponenten-Assay
DE68922844T2 (de) Agglutinationsverfahren zur Bestimmung von mehreren Liganden.
DE3686116T2 (de) Feststoffphase analytische einrichtung und verfahren zu ihrer verwendung.
DE3781335T2 (de) Immunoassay mit verwendung von kolloidalem gold.
DE68924064T2 (de) Verfahren zur Bestimmung eines oder mehrerer Analyte durch Anwendung verschiedene Typen von Partikeln, welche durchflusszytometrisch unterschieden sind.
EP0126450B1 (de) Partikel sowie Verfahren zum Nachweis von Antigenen und/oder Antikörpern unter Verwendung der Partikel
DE69125992T2 (de) Verfahren und Kit für Immunoassay
DE69920512T2 (de) Teststab für kohlenhydrat-freien transferrintest
DE3618101C2 (enExample)
DE69032854T2 (de) Verfahren, reagenzien und testkits zum nachweis von subpopulationen biologischer substanzen
DE3329728C2 (enExample)
DE3685600T2 (de) Stabilisierte fluoreszierende seltenerd-indikatoren und physiologisch-reaktive kennsatz-spezies.
DE68911674T2 (de) Testverfahren und reagenzsatz dazu.
DE3887491T2 (de) Chromatographische Bindungstesteinrichtungen und Verfahren.
DE69414001T2 (de) Bestimmungsmethode
DE69333050T2 (de) Anordnung zur probenbestimmung
DE69131181T2 (de) Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation
DE2512730A1 (de) Verfahren zum nachweis einer immunologischen reaktion und zur bestimmung der konzentration immunologisch reaktiver biologischer teilchen sowie vorrichtung zur durchfuehrung des verfahrens
EP0407904B1 (de) Verfahren zur Bestimmung eines Analyten
DE60317484T2 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
DE69524576T2 (de) Küvette für eine analysevorrichtung, verfahren und diagnostischer testsatz zur feststellung von analyten in vollblutproben
DE3883729T2 (de) Immunobestimmung mit Nichtmetallmarkierungen.
DE69211805T2 (de) Testsatz und Verfahren zum Nachweiss von Mikroorganismen assoziiert mit periodontalen Krankheiten unter Verwendung Surfactantmischung als Extraktionskomposition
DE3883652T2 (de) Verfahren zum sortieren von zellen.
DE69013730T2 (de) Für ganze Zellen geeigneter Satz und Verfahren zu enzymatischen Bestimmungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee